What is the Tauns Laboratories Inc. stock price forecast?

Tauns Laboratories Inc. is currently trading at ¥484. View real-time AI analysis on Alpha Lenz.

What is Tauns Laboratories Inc. insider trading activity?

View the latest insider trading data for Tauns Laboratories Inc. on Alpha Lenz.

What is Tauns Laboratories Inc.'s P/E ratio?

Tauns Laboratories Inc.'s P/E ratio is 7.8.

Tauns Laboratories Inc.

JPX · 197A

¥484-1(-0.21%)Market closed

Ask about Tauns Laboratories Inc.'s future dividend policy...

Alpha Chat Insight

“Tauns Laboratories Inc. trades at a P/E of 7.8 (undervalued) with strong ROE of 40.6%. Operating margin of 44.4% indicates strong profitability.”

Ask for details →

Company Overview

Tauns Laboratories Inc. is a company that operates within the healthcare and life sciences sector, focusing on the development and manufacturing of diagnostics and medical testing equipment. Its primary function is to provide innovative solutions for the detection and management of diseases, enhancing healthcare efficacy through precise diagnostic tools. Tauns Laboratories Inc. is notable for its contributions to the medical diagnostics industry, especially in fields such as infectious diseases and genetic testing. By focusing on cutting-edge technology and research, the company addresses critical health needs and improves patient outcomes. In the financial market, Tauns Laboratories Inc. plays a significant role by supporting healthcare institutions and laboratories worldwide with reliable diagnostic products. The company's advancements in diagnostics not only drive the healthcare sector forward but also impact public health policies and practices.

Websitehttps://www.tauns.co.jp

SectorHealthcare

IndustryMedical Instruments & Supplies

Company Statistics

FY 2025

Profile

¥49,242,160,000Market Cap

¥18,627,990,000Revenue

0.00Shares Out

0Employees

Margins

68.58%Gross

48.52%EBITDA

44.37%Operating

44.03%Pre-Tax

33.90%Net

Valuation

7.80P/E

2.83P/B

2.64EV/Sales

6.02EV/EBITDA

29.02P/FCF

Growth (CAGR)

2.19%Rev 3Yr

N/ARev 5Yr

-9.61%Op Inc 3Yr

N/AOp Inc 5Yr

12.12%Net Inc 3Yr

N/ANet Inc 5Yr

Returns

19.20%ROA

40.63%ROE

25.25%ROIC

Financial Health

¥9,266,630,000Cash & Cash Equivalents

¥9,830,997,000Net Debt

109.65%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Tauns Laboratories Inc. trades at a P/E of 7.8 (undervalued) with strong ROE of 40.6%. Operating margin of 44.4% indicates strong profitability.”

Ask for details →

Frequently Asked Questions

Tauns Laboratories Inc. (ticker: 197A) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). Market cap is $49.2B.

The current price is 484 with a P/E ratio of 7.8x and P/B of 2.83x.

ROE is 40.63% and operating margin is 44.37%. Annual revenue is $18.6B.